CRSP
#1278
CRISPR Therapeutics AG - Common Shares
55.6 8 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.28%
Changement Mensuel
+15.90%
Evolution sur 6 mois
-4.07%
Changement Annuel
+9.18%
Clôture Précédente
56.9 8
Open
56.2 2
Low
55.4 3
High
56.6 2
Volume
368
Financials
- Market Capitalization 5.38 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-11.58
ratio cours/chiffre d'affaires
389.54
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1242 |  PTCT PTC Therapeutics, Inc. - Common Stock | 69.66 USD | +0.17% | -3.46% | +3.69% | +40.81% | 5.81 B USD | ||
| 1259 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 285.78 USD | +0.59% | -0.62% | -0.47% | +52.73% | 5.70 B USD | ||
| 1299 |  DFTX Definium Therapeutics, Inc. - Common Shares | 39.52 USD | -0.50% | -11.61% | -7.81% | +161.55% | 5.31 B USD | ||
| 1348 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 28.91 USD | 0.00% | -4.27% | +11.32% | +11.58% | 4.98 B USD |